# DiaMedica Therapeutics Inc.: Form 8-K, filed Dec 11, 2018

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: 8-K
- Filed: 2018-12-11
- Accepted by EDGAR: Dec 11, 2018, 16:06 ET
- Period: 2018-12-06
- Accession: 0001437749-18-021894
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774918021894/dmtp20181207_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774918021894/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774918021894/dmtp20181207_8k.htm

Filed Dec 11, 2018.
Source: SEC EDGAR, the filing index for accession 0001437749-18-021894. Last ingested by Listed: Nov 13, 2026, 16:25 ET. No prices; not investment advice.
